HomeInsightsMarket Capitalization

Market Capitalization of Bafna Pharmaceuticals Ltd

Market Capitalization of Bafna Pharmaceuticals Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Jan 3, 2025)

stocks purchased

0.2 K

Stocks Traded

(Jan 3, 2025)

Last Updated on: Jan 05, 2025

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Market Cap

₹ 193.98 crore

Last updated on: Jan 03, 2025

Key Highlights

  • The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 193.98 crore as of 03 Jan 25 .
  • The Market Cap of Bafna Pharmaceuticals Ltd is ₹ 2.1 crore as of March 2020 .
  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 82 as of 03 Jan 15:30 .
Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Market Cap

₹ 2.1 crore

Last updated on: Invalid Date

Company Fundamentals for Bafna Pharmaceuticals Ltd

No data available

Image

Bafna Pharmaceuticals Ltd

NSE: BAFNAPH

Share Price

₹ 82

-1.95 (-2.32%)

stock direction

Last updated on: Jan 03, 2025

Market Price of Bafna Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Bafna Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Jan 202582
02 Jan 202583.95
01 Jan 202580.32
31 Dec 202476.5
30 Dec 202478.23
27 Dec 202480.99
23 Dec 202482
20 Dec 202481
19 Dec 202481.29
18 Dec 202478

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bafna Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Bafna Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Bafna Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Bafna Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 2024 18:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 2024 10:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 2024 17:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 2024 13:56

News

Bafna Pharmaceuticals to hold board meeting

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 M...

Read more

28 May 2024 13:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 F...

Read more

03 Feb 2024 14:11

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Bafna Pharmaceuticals Ltd Market Cap

What is the market cap of Bafna Pharmaceuticals Ltd?

As of January 5, 2025, Bafna Pharmaceuticals Ltd has a market capitalization of ₹193.98, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Bafna Pharmaceuticals Ltd's market capitalization?

Bafna Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Bafna Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Bafna Pharmaceuticals Ltd's market capitalization change?

Bafna Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions